Alnylam Pharmaceuticals target price cut to $250 from $260 by Jefferies
ALNY•Jefferies cut its target price for Alnylam Pharmaceuticals to $250 from $260.
Related News
First Solar to report third-quarter financial results
FSLR•
BlackRock increases total voting rights in Symrise to 9.02% from 8.79%
BLK•
Megadeals account for over 76% of 2026 PE capital invested, SS&C Intralinks report finds
SSNC•
Commercial Metals jumps after Q4 results beat estimates
CMC•
Evergy publishes update to financial calendar
EVRG•